Ramin Tadayoni, MD, PhD and Carl Regillo, MD
Show Description +
How useful is vitrectomy to address vitreous hemorrhage (VH) secondary to retinal vein occlusion (RVO)? Clinical Minute: Retina founding host Ramin Tadayoni, MD, PhD, sits down with Carl Regillo, MD, to review the findings from a recent study he co-authored, and explores the depth and breadth of complications that may occur after vitrectomy for VH secondary to RVO. This interview, recorded toward the end of 2023, is Prof. Tadayoni's final installment of Clinical Minute: Retina. The Eyetube team is honored to have helped him accomplish his overarching goal: to showcase the important work of his colleagues and to move the field of retina forward. We all will miss him very much. Let this be a reminder of the great light he shined on the world of retina both personally and professionally. Going forward, María Berrocal, MD, will join us as the host of Clinical Minute: Retina. We look forward to carrying this series forward under her guidance. This episode is editorially independent and supported with advertising by Genentech.
Posted: 5/23/2024
Ramin Tadayoni, MD, PhD and Carl Regillo, MD
How useful is vitrectomy to address vitreous hemorrhage (VH) secondary to retinal vein occlusion (RVO)? Clinical Minute: Retina founding host Ramin Tadayoni, MD, PhD, sits down with Carl Regillo, MD, to review the findings from a recent study he co-authored, and explores the depth and breadth of complications that may occur after vitrectomy for VH secondary to RVO. This interview, recorded toward the end of 2023, is Prof. Tadayoni's final installment of Clinical Minute: Retina. The Eyetube team is honored to have helped him accomplish his overarching goal: to showcase the important work of his colleagues and to move the field of retina forward. We all will miss him very much. Let this be a reminder of the great light he shined on the world of retina both personally and professionally. Going forward, María Berrocal, MD, will join us as the host of Clinical Minute: Retina. We look forward to carrying this series forward under her guidance. This episode is editorially independent and supported with advertising by Genentech.
Posted: 5/23/2024
Please log in to leave a comment.